Vaccinations and the risk of relapse in multiple sclerosis

New England Journal of Medicine

Volumn 344, Issue 5, 2001, Pages 319-326

  Confavreux, Christian ^a   Suissa, Samy ^b,c   Saddier, Patricia ^d   Bourdès, Valérie ^a   Vukusic, Sandra ^a  

^a HÔPITAL NEUROLOGIQUE   (France)

^b ROYAL VICTORIA HOSPITAL   (Canada)

^c MCGILL UNIVERSITY   (Canada)

^d SANOFI PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA TETANUS TOXOID; HEPATITIS A VACCINE; HEPATITIS B VACCINE; INFLUENZA VACCINE; TETANUS TOXOID; TYPHOID PARATYPHOID VACCINE; TYPHOID VACCINE; YELLOW FEVER VACCINE;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG EXPOSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIPLE SCLEROSIS; ONSET AGE; PRIORITY JOURNAL; RELAPSE; RISK ASSESSMENT; VACCINATION;

ADULT; CASE-CONTROL STUDIES; FEMALE; HUMANS; INFLUENZA VACCINES; LOGISTIC MODELS; MALE; MULTIPLE SCLEROSIS; RECURRENCE; RISK; TETANUS TOXOID; VACCINATION; VIRAL HEPATITIS VACCINES;

EID: 0035253662     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200102013440501     Document Type: Article

References (51)

1. The possible role of vaccines and sera in the pathogenesis of multiple sclerosis
2. Infection and immunization in multiple sclerosis
3. La vacunación antidiftérica como factor desencadenante de la esclerosis múltiple
4. Multiple sclerosis and vaccination
5. Disseminated sclerosis syndrome following antirabic vaccination
6. Relapsing encephalomyelitis following the use of influenza vaccine
7. A prospective study of parapareses in western Sweden
8. Swine-influenza vaccine
9. Postvaccinal neurological complication: Report of 12 cases
10. The role of infection and vaccination in the genesis of optic neuritis and multiple sclerosis in children
11. Central-nervous-system demyelination after immunisation with recombinant hepatitis B vaccine
12. Myélite aigüe aprés vaccination contre l'hépatite B
13. Multiple sclerosis and hepatitis B vaccination
14. Transverse myelitis following hepatitis B vaccination
15. Bilateral optic neuritis with branch retinal artery occlusion associated with vaccination
16. Central nervous system demyelination after vaccination against hepatitis B and HLA haplo-type
17. MR imaging in a case of postvaccination myelitis
18. Neuropapillite bilatérale avec décollement séreux du neuroépithélium, au décours d'une vaccination contre l'hépatite B
19. Myélite aigüe après immunisation contre l'hépatite B par un vaccin recombinant
20. Central nervous system demyelination after recombinant hepatitis B vaccination: Report of 25 cases
21. Swine flu vaccine and multiple sclerosis
22. Postmarketing surveillance for neurologic adverse events reported after hepatitis B vaccination: Experience of the first three years
23. The possible risk of vaccinations for the first manifestation of multiple sclerosis
24. Vaccination of patients with encephalomyelitis disseminata
25. Adverse events after hepatitis B vaccination
26. Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons
27. Recombinant hepatitis B vaccination of neonates and infants: Emerging safety data from the vaccine adverse event reporting system
28. Comparaison entre les risques de premières atteintes démyélinisantes centrales aigües et les bénéfices de la vaccination contre l'hépatite B
29. Immune status of patients with multiple sclerosis: Analysis of primary and established immune responses in 24 patients
30. Influenza vaccination in patients with multiple sclerosis
31. Swine influenza virus vaccination in patients with multiple sclerosis
32. Swine influenza vaccination in patients with multiple sclerosis
33. Serial magnetic resonance imaging studies with paramagnetic contrast medium: Assessment of disease activity in patientS with multiple sclerosis before and after influenza vaccination
34. Clinical and MRI assessment of disease activity in patients with multiple sclerosis after influenza vaccination
35. A multicenter, randomized, double-blind, placebo-controlled trial of influenza immunization in multiple sclerosis
36. Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis
37. Association between hepatitis B vaccine and multiple sclerosis: A case-control study
38. Vaccinations, Demyelination and Multiple Sclerosis Study (VDAMS): A population-based study in the UK
39. Premier épisode de démyélinisation du système nerveux central et vaccination contre l'hépatite B: Étude cas-témoins pilote
40. EDMUS, a European database for multiple sclerosis
41. Pregnancy in multiple sclerosis group. Rate of pregnancy-related relapse in multiple sclerosis
42. New diagnostic criteria for multiple sclerosis: Guidelines for research protocols
43. Course and prognosis of multiple sclerosis assessed by the computerized data processing of 349 patients
44. Defining the clinical course of multiple sclerosis: Results of an international survey
45. Rating neurologic impairment in multiple sclerosis: An Expanded Disability Status Scale (EDSS)
46. The case-crossover design: A method for studying transient effects on the risk of acute events
47. Use of Bacille Calmette-Guérin (BCG) in multiple sclerosis
48. No increase in demyelinating diseases after hepatitis B vaccination
49. School-based hepatitis B vaccination programme and adolescent multiple sclerosis
50. Risk of cancer from azathioprine therapy in multiple sclerosis: A case-control study